A Study to Assess Nomlabofusp in Adolescents and Children with Friedreich's Ataxia

Nomlabofusp is a recombinant fusion protein provided in a sterile, preservative-free buffered solution for subcutaneous injection intended to deliver human frataxin, the protein deficient in Friedreich's ataxia.

The placebo is a sterile, preservative-free, clear liquid for subcutaneous injection.